Company Filing History:
Years Active: 1996-2002
Title: The Innovations of Ronald J Weigel
Introduction
Ronald J Weigel is a prominent inventor based in Woodside, CA (US). He has made significant contributions to the field of neuroscience, particularly in the development of neuroprotective agents. With a total of 3 patents, his work focuses on the therapeutic potential of GPR30 receptor ligands.
Latest Patents
Weigel's latest patents include groundbreaking research on the use of GPR30 receptor ligands to mediate neurotrophic action. This innovation aims to prevent or treat neurological dysfunction through the administration of ligands that activate the GPR30 receptor. These ligands, which include estrogens and structurally related molecules, are designed to be orally available drugs that can effectively cross into the brain from the bloodstream. Additionally, he has developed a method for screening neuroprotective agents that do not activate other estrogen receptors, thereby avoiding the classical estrogenic effects associated with these receptors.
Career Highlights
Weigel is affiliated with Leland Stanford Junior University, where he continues to advance his research in neurobiology. His work has garnered attention for its potential to revolutionize treatments for neurological disorders.
Collaborations
Some of his notable coworkers include William C Mobley and Chengbiao Wu, who have contributed to his research endeavors.
Conclusion
Ronald J Weigel's innovative work in the field of neuroscience highlights the importance of GPR30 receptor ligands in developing new therapeutic strategies. His contributions are paving the way for advancements in treating neurological dysfunctions.